Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples